31 January 2022>: Meta-Analysis
Utility of Pretreatment Blood Platelet-To-Lymphocyte Ratio in Prediction of Clinical Outcomes and Chemosensitivity in Patients with Advanced Gastric Cancer: A Meta-Analysis
Xiulan Peng 1AE* , Wei Zeng 2BF* , Bing Tang 3CF* , Anbing He 1B , Min Zhang 1B , Renfeng Luo 4AB*DOI: 10.12659/MSM.933449
Med Sci Monit 2022; 28:e933449
Figure 3 Forest plots for the association platelet to lymphocyte ratio and disease-free survival in patients with advanced gastric cancer (HR=1.47, 95% CI=1.14–1.88, P=0.003). CI – confidence interval; HR – hazard ratio.